Publications by authors named "Daniel Sehrt"

Claim this Profile
I
Inherited and Acquired Determinants of Hepatic CYP3A Activity in Humans.
Johannes Matthaei, Wagner Hugo Bonat, Reinhold Kerb, Mladen Vassilev Tzvetkov, Jakob Strube, Daniel Sehrt

Front Genet· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Circadian PER2 Enhancer Nobiletin Reverses the Deleterious Effects of Midazolam in Myocardial Ischemia and Reperfusion Injury.
Yoshimasa Oyama, Colleen Marie Bartman, Jennifer Gile, Daniel Sehrt, Tobias Eckle

Curr Pharm Des· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters.
Johannes Matthaei, Mladen V Tzvetkov, Valerie Gal, Cordula Sachse-Seeboth, Daniel Sehrt

Genome Med· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial.
Ulrich Jaehde, Gerd Bendas, Daniel Sehrt, Joachim von Pawel

Int J Clin Pharmacol Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Annual meeting of CESAR in Tuebingen, Germany June 27-29, 2013.
Joachim von Pawel, Matthias Schwab, Daniel Sehrt

Int J Clin Pharmacol Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dual pathway inhibitor rigosertib is effective in direct patient tumor xenografts of head and neck squamous cell carcinomas.
Ryan T Anderson, Stephen B Keysar, Daniel W Bowles, Magdalena J Glogowska, David P Astling, Daniel Sehrt

Mol Cancer Ther· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins.
Stephen B Keysar, David P Astling, Ryan T Anderson, Brian W Vogler, Daniel W Bowles, Daniel B Sehrt

Mol Oncol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer.
Stephen B Keysar, Phuong N Le, Ryan T Anderson, J Jason Morton, Daniel W Bowles, Daniel B Sehrt

Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 10th annual meeting of CESAR in Essen June 28 - 30, 2012, Germany.
Ulrich Jaehde, Ralf Hilger, Thomas Gauler, Daniel Sehrt

Int J Clin Pharmacol Ther· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial. Approaches to personalized medicine in oncology--the 9th Annual Meeting of CESAR in Greifswald.
Christoph Ritter, Daniel Sehrt, Ulrich Jaehde

Int J Clin Pharmacol Ther· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane.
Xiangyang Xie, Zhenwei Gong, Virginie Mansuy-Aubert, Qiong L Zhou, Suren A Tatulian, Daniel Sehrt

Cell Metab· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carvedilol pharmacokinetics and pharmacodynamics in relation to CYP2D6 and ADRB pharmacogenetics.
Daniel Sehrt, Ingolf Meineke, Mladen Tzvetkov, Senol Gültepe, Jürgen Brockmöller

Pharmacogenomics· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Amelogenin-based sex identification as a strategy to control the identity of DNA samples in genetic association studies.
Mladen Vassilev Tzvetkov, Ingolf Meineke, Daniel Sehrt, Stefan Viktor Vormfelde, Jürgen Brockmöller

Pharmacogenomics· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent in vitro findings of negative inotropy of pantoprazole did not translate into clinically relevant effects on left ventricular function in healthy volunteers.
Wolfgang Schillinger, Nina Hörnes, Nils Teucher, Samuel Sossalla, Daniel Sehrt

Clin Res Cardiol· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bioinformatic and functional analysis of TGFBR1 polymorphisms.
Markus A Schirmer, Arne O Hoffmann, Radu Campean, Jörg H Janke, Laura M Zidek, Daniel Sehrt

Pharmacogenet Genomics· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anxiety- and novelty seeking-related personality traits and serotonin transporter gene polymorphisms.
Stefan Viktor Vormfelde, Imke Hoell, Mladen Tzvetkov, Katja Jamrozinski, Daniel Sehrt

J Psychiatr Res· September 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hydrochlorothiazide efficacy and polymorphisms in ACE, ADD1 and GNB3 in healthy, male volunteers.
Stefan Viktor Vormfelde, Daniel Sehrt, Daniela Bolte, Susanne Pahl, Mladen Tzvetkov

Eur J Clin Pharmacol· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis